COST-MINIMIZATION ANALYSIS AND BUDGET IMPACT OF GLYCOPYRRONIUM BROMIDE VERSUS TIOTROPIUM BROMIDE AS A MAINTENANCE BRONCHODILATOR TREATMENT IN PATIENTS WITH MODEREATE TO SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

被引：0
|
作者：
Ruiz Miranda, C., I [1 ]
Ubiarco Lopez, V [1 ]
Chavez Plascencia, E. [1 ]
机构：
[1] Novartis Mexico, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS28
引用
收藏
页码：A174 / A174
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of tiotropium bromide combined with budesonide/formoterol in the treatment of moderate to severe chronic obstructive pulmonary disease
    Zhao, Daguo
    Ling, Chunhua
    Guo, Qiang
    Jin, Jun
    Xu, Hua
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (06) : 4578 - 4584
  • [32] Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD)
    Ni, Han
    Htet, Aung
    Moe, Soe
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (06):
  • [33] Cost Effectiveness of Budesonide/Formoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary DiseaseAustralian, Canadian and Swedish Healthcare Perspectives
    Nicole Mittmann
    Paul Hernandez
    Carl Mellström
    Lance Brannman
    Tobias Welte
    PharmacoEconomics, 2011, 29 : 403 - 414
  • [34] Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease
    ZuWallack, AR
    ZuWallack, RL
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (08) : 1827 - 1835
  • [35] COMPARATIVE EFFICACY OF ACLIDINIUM BROMIDE 400 MCG BID VERSUS TIOTROPIUM 18 MCG AND 5 MCG QD AS MAINTENANCE BRONCHODILATOR TREATMENT TO RELIEVE SYMPTOMS IN ADULT PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): A NETWORK META-ANALYSIS
    Karabis, A.
    Lindner, L.
    Mocarski, M.
    Bouwmeester, W.
    Karakurum, C.
    Prior, M.
    Bergman, G.
    VALUE IN HEALTH, 2012, 15 (07) : A560 - A560
  • [36] Tiotropium Bromide Attenuates Mucus Hypersecretion in Patients with Stable Chronic Obstructive Pulmonary Disease
    Yu, Suyun
    Zhang, Caili
    Yan, Zhijun
    Fang, Qingqing
    Gao, Xiwen
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2021, 2021
  • [37] UMECLIDINIUM/VILANTEROL VERSUS TIOTROPIUM/OLODATEROL IN THE TREATMENT OF SEVERE TO VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) FROM THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE: A BUDGET IMPACT ANALYSIS
    Araujo, M.
    Silva, D.
    Bernardino, G.
    VALUE IN HEALTH, 2023, 26 (06) : S93 - S93
  • [38] Legal demands of the tiotropium bromide for treatment of chronic obstructive pulmonary disease and their financial impact for the State of Parana, Brazil
    Szpak, Renata
    Strapasson, Giovanna Chipon
    Boger, Beatriz
    Rattmann, Yanna Dantas
    Gomes, Eliane Carneiro
    EINSTEIN-SAO PAULO, 2020, 18 : eGS4442
  • [39] BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF TIOTROPIUM BROMIDE MONOHYDRATE-OLODATEROL HYDROCHLORIDE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE CHILEAN PUBLIC HEALTH SECTOR
    Lenz, R.
    Paredes, D.
    Hernandez, K.
    Paez, L.
    VALUE IN HEALTH, 2022, 25 (07) : S338 - S338
  • [40] Cost-effectiveness analysis of tiotropium for chronic obstructive pulmonary disease (COPD) patients in Japan
    Nishimura, S
    Kobayashi, M
    Hasegawa, T
    VALUE IN HEALTH, 2005, 8 (03) : 327 - 327
12345